Bain & Company September 23, 2019
As outpatient surgery centers perform a growing share of procedures, medtech leaders are rethinking their commercial strategies.
At a Glance
- The volume of procedures at ambulatory surgery centers is forecast to grow by 6% to 7% a year through 2021.
- Orthopedic, spine and cardio procedures will increase the fastest through the mid-2020s.
- Medtech companies’ traditional commercial model is too costly and complex for ambulatory surgery centers.
- Surgeons at ambulatory surgery centers have a greater propensity than those in hospitals to switch to a competing device manufacturer if offered a discount.
Ambulatory surgery centers (ASCs) are transforming healthcare delivery as well as the market for medical devices and equipment. By focusing on routine, lower-risk procedures in...
Today's Sponsors
Today's Sponsor